New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 5, 2012
10:01 EDTADT, SSTK, BSMX, RGLS, MUSA, KYTH, ICPT, CHTR, ANFI, AMBA, WDAYOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: ADT Corp. (ADT) initiated with a Buy at Citigroup... Ambarella (AMBA) initiated with a Buy at Deutsche Bank... Amira Nature Foods (ANFI) initiated with a Buy at Deutsche Bank... Charter (CHTR) initiated with an Underweight at Barclays... Intercept Pharmaceuticals (ICPT) initiated with a Buy at Needham... Kythera Biopharmaceuticals (KYTH) initiated with a Neutral at Goldman... Metals USA (MUSA) initiated with an Outperform at Wells Fargo... Regulus Therapeutics (RGLS) initiated with a Buy at Needham... Santander Mexico (BSMX) initiated with a Buy at Citigroup... Shutterstock (SSTK) initiated with a Buy at Jefferies... Workday (WDAY) initiated with a Buy at Canaccord.
Check below for free stories on ADT;AMBA;ANFI;CHTR;ICPT;KYTH;MUSA;RGLS;BSMX;SSTK;WDAY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 12, 2014
12:37 EDTICPTOn The Fly: Midday Wrap
Subscribe for More Information
11:10 EDTICPTHigh option volume stocks
10:18 EDTICPTIntercept rallies sharply, retraces, levels to watch
The shares gapped open to $345.62 this morning, rallied to a high of $349.08, and have since been moving lower in price. With last price at $307.03 the stock is not far from the top of the prior trading range which was near the $300 area. Holding above that $300 level is important if the stock is going to regain a bullish footing. A break back down into the prior range of $210 at the low and $300 at the high would leave the stock in neutral mode technically. Resistance is at $313.14, based on current price.
10:15 EDTICPTIntercept surges after reporting data for liver disease drug OCA
Subscribe for More Information
10:00 EDTICPTOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:21 EDTICPTOn The Fly: Pre-market Movers
Subscribe for More Information
08:32 EDTICPTIntercept Pharmaceuticals volatility expected to move on trial data
Subscribe for More Information
07:53 EDTICPTIntercept price target raised to $500 from $395 at Deutsche Bank
Subscribe for More Information
06:30 EDTICPTIntercept upgraded to Outperform from Market Perform at Leerink
Leerink upgraded Intercept to Outperform citing an increased probability of success in NASH following last night's data. The firm raised its price target for shares to $445 from $270 saying it was encouraged by the removal of the prior imbalance in serious adverse events.
06:20 EDTICPTIntercept upgraded to Outperform from Market Perform at Leerink
06:19 EDTICPTIntercept data for liver disease drug 'highly positive, says Citigroup
Subscribe for More Information
August 11, 2014
18:29 EDTICPTOn The Fly: After Hours Movers
UP AFTER EARNINGS: DealerTrack (TRAK), up 11.3%... DTS Inc. (DSTI), up 12.8%... Globalstar (GSAT), up 1.6%... Halozyme Therapeutics (HALO), up 2.4%. ALSO HIGHER: Intercept Pharmaceuticals (ICPT), up 57.7% after announcing that 46% of OCA group met FLINT endpoint as well as reporting second quarter results... Cempra (CEMP), up 5.8% following Intercept Pharmaceuticals' FLINT announcement... Scotts Miracle-Gro (SMG), up 3.6% after board approves a $500M share repurchase authorization and announces a $2.00 per share special dividend. DOWN AFTER EARNINGS: Galena Biopharma (GALE), down 13.4%... Nuance Communications (NUAN), down 9.7%... Millennial Media (MM), down 7.1%... MasTec (MTZ), down 3.6%... Turtle Beach (HEAR), down 3.5%... magicJack (CALL), down 5.8%... Geron (GERN), down 2.4%. ALSO LOWER: Sprouts Farmers Market (SFM), down 3.7% after filing to sell 15M shares of common stock for holders.
17:18 EDTICPTIntercept up 54% to $363 after OCA data, Q2 earnings
Subscribe for More Information
17:11 EDTICPTIntercept says 46% of OCA group met FLINT endpoint vs. 21% for placebo group
Subscribe for More Information
16:29 EDTKYTHKYTHERA submits new drug submission to Health Canada for ATX-101
Subscribe for More Information
16:24 EDTICPTIntercept reports Q2 EPS $1.51, may not compare to consensus (12c)
Subscribe for More Information
15:32 EDTICPTNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Ventas (VTR), consensus $1.09; Nuance Communications (NUAN), consensus 27c; Intercept Pharmaceuticals (ICPT), consensus (12c); Rackspace Hosting (RAX), consensus 16c; Opko Health (OPK), consensus (9c); Mindray Medical (MR), consensus 54c; Chimera Investment (CIM), consensus 9c; Globalstar (GSAT), one estimate (4c); 51job (JOBS), consensus 32c; Dealertrack Technologies (TRAK), consensus 373c; Caesars Entertainment (CZR), consensus ($1.19); Towerstream (TWER), consensus (10c); Resolute Energy (REN), consensus 1c; Forest Oil (FST), consensus (2c).
11:33 EDTWDAYWorkday rises after reportedly winning record deal with McDonald's
Shares of cloud-based human capital management solution provider Workday (WDAY) are rising after the company is said to have won a deal with global fast food giant McDonald's (MCD) that would be the biggest in its history. WHAT'S NEW: JMP Securities analysts Patrick Walravens and Peter Lowry wrote in a note to investors this morning that the firm's checks indicate that Workday was awarded the human capital management business at McDonald’s, which the analysts said could be the biggest deal in the company’s history. The firm increased its estimate for Workday's Q2 billings to $185M from $182M, noting that both are above the company's guidance of $180M in billing for Q2. JMP maintains its Market Outperform rating and $126 price target on Workday, but the analysts noted that they like the stock over the longer-term, citing its market leading position in the Software-as-a-Service Enterprise Resource Planning space, which is set to triple from 2013 to 2020. PRICE ACTION: In late morning trading, shares of Workday gained $2.43, or 2.9%, to $86.34.
06:49 EDTWDAYWorkday won human capital business at McDonald's, says JMP Securities
JMP Securities says its due diligence indicates Workday (WDAY) won the human capital management business at McDonald's (MCD). JMP believes the contract could be the biggest deal in Workday's history and it raised its Q2 billings estimate to $185M from $182M. The firm keeps an Outperform rating on Workday with a $126 price target.
August 8, 2014
06:34 EDTICPTIntercept volatility elevated into data
Intercept overall option implied volatility of 106 is above its 26-week average of 97 according to Track Data, suggesting large price movement into the expected release of Phase 2b FLINT 72 week data.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use